@article{2951269,
    title = "The Combination of Bortezomib, Melphalan, Dexamethasone and Intermittent Thalidomide (VMDT) Is an Effective Regimen for Relapsed/Refractory Myeloma and Reduces Serum Levels of Dickkopf-1, RANKL, MIP-1$\alpha$ and Angiogenic Cytokines.",
    author = "Terpos, Evangelos and Anagnostopoulos, Athanasios and Heath, Deborah and Kastritis, Efstathios and Christoulas, Dimitrios and Anagnostopoulos, Nikolaos and Roussou, Maria and Tsionos, Konstantinos and Croucher, Peter and Dimopoulos, Meletios A",
    journal = "Blood Disease Weekly",
    year = "2006",
    volume = "108",
    number = "11",
    pages = "3541",
    publisher = "Content Repository Only!"
}